SCHEMBL29571237

SCHEMBL29571237

CC1(C)c2ccccc2-c2ccc3ccccc3c21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.45
KMT2A Q03164 5/20 0.45
MAPT P10636 4/20 0.44
KDM4E B2RXH2 3/20 0.44
TDP1 Q9NUW8 2/20 0.44
HTT P42858 2/20 0.44
LMNA P02545 1/20 0.44
THRB P10828 1/20 0.44
APEX1 P27695 1/20 0.44
RECQL P46063 1/20 0.44
MAPK1 P28482 1/20 0.42
ALDH1A1 P00352 5/20 0.39
CYP2A6 P11509 3/20 0.39
TSHR P16473 2/20 0.39
HSD17B10 Q99714 2/20 0.39
DNMT1 P26358 1/20 0.38
KIF11 P52732 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
CYP1A2 P05177 2/20 0.37
HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16062607 1.00 MEN1 (0.45) MEN1KMT2AMAPTKDM4ETDP1
SCHEMBL3748294 0.86 MEN1 (0.52) MEN1KMT2AMAPTKDM4ETDP1
SCHEMBL21693386 0.82 MEN1 (0.40) MEN1KMT2AMAPTKDM4ETDP1
SCHEMBL16062622 0.82 MEN1 (0.42) MEN1KMT2AMAPTKDM4ETDP1
SCHEMBL24742922 0.82 PDK2 (0.38) MEN1KMT2AMAPTKDM4ETDP1
SCHEMBL2687147 0.82 CYP2A6 (0.40) MEN1KMT2AMAPTKDM4ETDP1
SCHEMBL19002139 0.82 MCL1 (0.41) MEN1KMT2AMAPTKDM4ETDP1
SCHEMBL13828968 0.82 CYP2A6 (0.40) MEN1KMT2AMAPTKDM4ETDP1
SCHEMBL24524400 0.82 CTDSP1 (0.41) MEN1KMT2AMAPTKDM4ETDP1
SCHEMBL17151872 0.82 KDM4E (0.37) MEN1KMT2AMAPTKDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114437006-B Organic compound and application thereof 北京鼎材科技有限公司 2024-09-27 CN disclosed
US-20240251665-A1 TRANSVERSE CURRENT SUPPRESSING MATERIAL, CARBAZOLE COMPOUND, HOLE-INJECTION LAYER AND ORGANIC ELECTROLUMINESCENT ELEMENT TOSOH CORPORATION (JP) 2024-07-25 US disclosed
WO-2022211123-A1 TRANSVERSE CURRENT SUPPRESSING MATERIAL, CARBAZOLE COMPOUND, HOLE INJECTION LAYER, AND ORGANIC ELECTROLUMINESCENT ELEMENT 東ソー株式会社 2022-10-06 WO disclosed
CN-114437006-A Organic compound and application thereof 北京鼎材科技有限公司 2022-05-06 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240251665-A1 TRANSVERSE CURRENT SUPPRESSING MATERIAL, CARBAZOLE COMPOUND, HOLE-INJECTION LAYER AND ORGANIC ELECTROLUMINESCENT ELEMENT AXIN2, FZD7, SLC39A3 MEN1 1023/4885KMT2A 2097/4885MAPT 3209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.